DrugDashboards

Prochlorperazine Edisylate

Prochlorperazine Edisylate · PROCHLORPERAZINE EDISYLATE 5 mg/mL · Injection · Intramuscular; Intravenous · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

NDC 23155-0294-41 · 25 VIAL in 1 PACKAGE / 2 mL in 1 VIAL · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$2.76per billing unit (10 MG)HCPCS J0780 · Jul 1, 2026
  • Part D plans paid (avg)$2.66per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$136.00
Reported to Texas DSHS · 2026 annual filing · Heritage Pharmaceuticals, Inc. d/b/a Avet Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$2.762
HCPCS J0780 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$38,753
3,643 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $90.46 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA204147
TE code
AP
Approval date
Oct 15, 2013
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class I · TerminatedMay 21, 2019
    Heritage Pharmaceuticals, Inc. — Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Manufacturers of Prochlorperazine Edisylate (Injection)

LabelerStrengthFirst seenLast seen
Gland Pharma LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cosette Pharmaceuticals, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma Usa IncPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Prochlorperazine Edisylate — NDC 23155-0294-41," retrieved September 3, 2026, https://drugdashboards.com/drug/23155029441.

Free to cite with attribution — see how the data is put together.